Johnson FR, Hauber AB, Ozdemir S, Siegel CA, Sands BE, Hass S. Quantitative benefit-risk tradeoff preferences for Crohn's Disease treatments: implications for regulatory decision making and disease management. Int J Med Biol Front. 2009 May 1;15(5/6):457-66.

Abstract not available at this time

Share on: